Treg-driven magnetic resonance radiomics in glioblastoma: a multicenter and cross-species model for prognostic biomarker discovery

Key Points

• Prognostic biomarkers derived from radiomics indicate favorable outcomes in glioblastoma patients with Treg activity.
• Key metrics include significant associations between Treg-driven features and glioblastoma progression rates.
• Observational analysis across multiple centers utilized cross-species models to assess radiomic data correlated with Treg status.
• This highlights potential therapeutic targets but may require further validation in clinical settings.